EMA Explains How To Minimize Trial Disruptions In Face Of Political Conflicts, Natural Disasters
Executive Summary
With major disruptions to clinical trials becoming more commonplace due to political conflicts and natural disasters, the European Medicines Agency has developed guidance to help sponsors make risk-based adjustments to manage ongoing studies.